Advertisement
Singapore markets closed
  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     
  • S&P 500

    5,008.19
    -63.44 (-1.25%)
     
  • Dow

    37,867.41
    -593.51 (-1.54%)
     
  • Nasdaq

    15,442.87
    -269.88 (-1.72%)
     
  • Bitcoin USD

    63,509.99
    -1,372.04 (-2.11%)
     
  • CMC Crypto 200

    1,372.48
    -10.09 (-0.73%)
     
  • FTSE 100

    8,070.27
    +29.89 (+0.37%)
     
  • Gold

    2,346.50
    +8.10 (+0.35%)
     
  • Crude Oil

    82.24
    -0.57 (-0.69%)
     
  • 10-Yr Bond

    4.7040
    +0.0520 (+1.12%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     
  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Will This Beaten-Down Stock Bounce Back? 3 Things to Know

Will This Beaten-Down Stock Bounce Back? 3 Things to Know

Vertex Pharmaceuticals (NASDAQ: VRTX) has given more than one investor a headache over the past year. Investors worry that Vertex is struggling to expand beyond its core portfolio of cystic fibrosis (CF) treatments. Considering the time Vertex shares have spent in the doldrums, you may be getting a little impatient.